Volume 10, supplement issue 1, December 2015
First European Congress on Hereditary ATTR amyloidosis
116 articles in this issue
-
-
Neuropathic phenotypes and natural history of FAP
Authors
- David Adams
- Content type: Invited speaker presentation
- Open Access
- Published: 02 November 2015
- Article: I2
-
Which assessment for the carriers: the cardiac view
Authors
- Arnt V Kristen
- Content type: Invited speaker presentation
- Open Access
- Published: 02 November 2015
- Article: I3
-
When to decide to enroll a TTR-FAP patient in a Clinical Trial?
Authors
- Juan Buades
- Content type: Invited speaker presentation
- Open Access
- Published: 02 November 2015
- Article: I4
-
Preimplantation genetic diagnosis for TTR-FAP in Portugal
Authors
- Filipa Carvalho
- Content type: Invited speaker presentation
- Open Access
- Published: 02 November 2015
- Article: I5
-
TTR-FAP: liver transplant vs oral medication. How and when
Authors
- Teresa Coelho
- Content type: Invited speaker presentation
- Open Access
- Published: 02 November 2015
- Article: I6
-
Which assessment for the carriers ? The point of view of the neurologist
Authors
- Isabel Conceicão
- Content type: Invited speaker presentation
- Open Access
- Published: 02 November 2015
- Article: I7
-
ATTR-FAP: liver transplantation vs oral medication, how and when
Authors
- Bo Goran Erikzon
- Content type: Invited speaker presentation
- Open Access
- Published: 02 November 2015
- Article: I8
-
Ophtalmologic changes in transthyretin familial amyloid polyneuropathy (ATTR-FAP)
Authors
- Natália Ferreira
- Content type: Invited speaker presentation
- Open Access
- Published: 02 November 2015
- Article: I9
-
Imaging cardiac ATTR amyloid
Authors
- Philip N Hawkins
- Content type: Invited speaker presentation
- Open Access
- Published: 02 November 2015
- Article: I10
-
Minimal assessment of index cases: the point of view of the neurologist
Authors
- Ernst Hund
- Content type: Invited speaker presentation
- Open Access
- Published: 02 November 2015
- Article: I11
-
The landscape of treatment of chronic kidney disease in hereditary ATTR amyloidosis
Authors
- Luisa Lobato
- Content type: Invited speaker presentation
- Open Access
- Published: 02 November 2015
- Article: I12
-
Do we need to demonstrate Amyloid in tissue?
Authors
- Laurent Magy
- Content type: Invited speaker presentation
- Open Access
- Published: 02 November 2015
- Article: I13
-
Emerging CNS involvement in FAP-TTR long survival patients
Authors
- Luisa Maia
- Content type: Invited speaker presentation
- Open Access
- Published: 02 November 2015
- Article: I14
-
Biopsy experience in a FAP endemic area
Authors
- Manuel Melo Pires
- Content type: Invited speaker presentation
- Open Access
- Published: 02 November 2015
- Article: I15
-
New tools to diagnose and follow FAC patients: biomarkers
Authors
- Giampaolo Merlini
- Content type: Invited speaker presentation
- Open Access
- Published: 02 November 2015
- Article: I16
-
New therapeutic perspectives – amyloid removal
Authors
- Mark Pepys
- Content type: Invited speaker presentation
- Open Access
- Published: 02 November 2015
- Article: I17
-
Cardiologic Phenotypes and Natural History of FAC
Authors
- Claudio Rapezzi
- Content type: Invited speaker presentation
- Open Access
- Published: 02 November 2015
- Article: I18
-
TTR amyloidosis: a scientific journey since Andrade
Authors
- Maria João Saraiva
- Content type: Invited speaker presentation
- Open Access
- Published: 02 November 2015
- Article: I19
-
Guidelines for genetic counselling in ATTR amyloidosis
Authors
- Jorge Sequeiros
- Content type: Invited speaker presentation
- Open Access
- Published: 02 November 2015
- Article: I20
-
Minimal assessment of the index case: the point of view of the cardiologist
Authors
- Michel Slama
- Content type: Invited speaker presentation
- Open Access
- Published: 02 November 2015
- Article: I21
-
Heart transplantation in hereditary ATTR amyloidosis
Authors
- M Slama
- Content type: Invited speaker presentation
- Open Access
- Published: 02 November 2015
- Article: I22
-
Treatment of gastrointestinal complication in transthyretin amyloidosis. A single centre’s experience
Authors
- Ole B Suhr
- Content type: Invited speaker presentation
- Open Access
- Published: 02 November 2015
- Article: I23
-
Therapeutic education programme in TTR-FAP
Authors (first, second and last of 15)
- Marie Théaudin
- Cécile Cauquil
- David Adams
- Content type: Invited speaker presentation
- Open Access
- Published: 02 November 2015
- Article: I24
-
Do we need to demonstrate amyloid in tissue for hereditary ATTR amyloidosis ?
Authors
- Per Westermark
- Content type: Invited speaker presentation
- Open Access
- Published: 02 November 2015
- Article: I25
-
TTR-FAP: a single-center experience in Sicily, an Italian endemic area
Authors (first, second and last of 8)
- Anna Mazzeo
- Massimo Russo
- Giuseppe Vita
- Content type: Oral presentation
- Open Access
- Published: 02 November 2015
- Article: O1
-
Epidemiology of Familial Amyloid Polyneuropathy in Bulgaria
Authors (first, second and last of 8)
- Stayko Sarafov
- Mariana Gospodinova
- Ivailo Tournev
- Content type: Oral presentation
- Open Access
- Published: 02 November 2015
- Article: O2
-
Unravelling the epidemiology of late-onset and asymptomatic carriers of FAP ATTR V30M in a Portuguese population
Authors (first, second and last of 6)
- Carolina Lemos
- Teresa Coelho
- Alda Sousa
- Content type: Oral presentation
- Open Access
- Published: 02 November 2015
- Article: O3
-
The hidden story behind gender differences in familial amyloid polyneuropathy (FAP) ATTRV30M
Authors (first, second and last of 8)
- Diana Santos
- Teresa Coelho
- Carolina Lemos
- Content type: Oral presentation
- Open Access
- Published: 02 November 2015
- Article: O4
-
Clinical, epidemiological, genetic, and electrophysiological characteristics of transthyretin familial amyloid polyneuropathies in Israel
Authors (first, second and last of 4)
- Menachem Sadeh
- Avi Livneh
- Alexander Lossos
- Content type: Oral presentation
- Open Access
- Published: 02 November 2015
- Article: O5
-
Familial amyloidotic polyneuropathy in Crete, Greece
Authors (first, second and last of 6)
- Minas Tzagournissakis
- Cleanthe Spanaki
- Panayiotis Mitsias
- Content type: Oral presentation
- Open Access
- Published: 02 November 2015
- Article: O6
-
The phenotypical expression of an European inherited TTR amyloidosis in Brazil
Authors (first, second and last of 5)
- Márcia Waddington Cruz
- Débora Foguel
- Priscila Ferreira da Silva
- Content type: Oral presentation
- Open Access
- Published: 02 November 2015
- Article: O7
-
DISCOVERY: a study examining the prevalence of transthyretin mutations in subjects suspected of having cardiac amyloidosis
Authors (first, second and last of 8)
- Olakunle Akinboboye
- Karthik Ananthasubramaniam
- Mathew S Maurer
- Content type: Oral presentation
- Open Access
- Published: 02 November 2015
- Article: O8
-
Wild-type transthyretin amyloidosis in female patients
Authors (first, second and last of 7)
- Arnt V Kristen
- Ralf Bauer
- Hugo A Katus
- Content type: Oral presentation
- Open Access
- Published: 02 November 2015
- Article: O9
-
Analysis of disease progression in patients with transthyretin cardiac amyloidosis
Authors (first, second and last of 8)
- Julian D Gilmore
- Mathew S Maurer
- Philip N Hawkins
- Content type: Oral presentation
- Open Access
- Published: 02 November 2015
- Article: O10
-
Vasculopathy in transthyretin Val30Met familial amyloid polyneuropathy
Authors (first, second and last of 7)
- Haruki Koike
- Shohei Ikeda
- Gen Sobue
- Content type: Oral presentation
- Open Access
- Published: 02 November 2015
- Article: O11
-
Neurophysiological pitfalls in TTR-FAP Val30Met
Authors (first, second and last of 4)
- Isabel Conceição
- Cristiana Silva
- José Castro
- Content type: Oral presentation
- Open Access
- Published: 02 November 2015
- Article: O12
-
Misdiagnoses of transthyretin amyloidosis: a clinical and electrodiagnostic study
Authors (first, second and last of 7)
- Andrea Cortese
- Alessandro Lozza
- Laura Obici
- Content type: Oral presentation
- Open Access
- Published: 02 November 2015
- Article: O13
-
Quantitative MR-neurographic parameters can determine and specify nerve injury in amyloid related polyneuropathy
Authors (first, second and last of 8)
- Jennifer Kollmer
- Ernst Hund
- Mirko Pham
- Content type: Oral presentation
- Open Access
- Published: 02 November 2015
- Article: O14
-
Positron Emission Tomography (PET) utilizing Pittsburgh compound B (PIB) detects amyloid heart deposits in hereditary transthyretin amyloidosis (ATTR).
Authors (first, second and last of 8)
- Björn Pilebro
- Per Lindqvist
- Jens Sörensen
- Content type: Oral presentation
- Open Access
- Published: 02 November 2015
- Article: O15
-
DPD Scintigraphy for diagnosis of amyloidosis in 1191 patients– a single centre experience
Authors (first, second and last of 8)
- David Hutt
- Helen Mcphillips
- Philip Hawkins
- Content type: Oral presentation
- Open Access
- Published: 02 November 2015
- Article: O16
-
Multi-modality imaging in cardiac ATTR amyloidosis: agreement between echocardiography, MRI and DPD-scintigraphy
Authors (first, second and last of 8)
- Ludivine Eliahou
- Renata Chequer
- François Rouzet
- Content type: Oral presentation
- Open Access
- Published: 02 November 2015
- Article: O17
-
ATTR Amyloidosis: development of cardiac symptoms during 6 years of follow up in different ATTR-variants
Authors (first, second and last of 6)
- Sebastiaan Klaassen
- Jasper Tromp
- Peter Van Der Meer
- Content type: Oral presentation
- Open Access
- Published: 02 November 2015
- Article: O18
-
Ocular manifestations of transthyretin-related familial amyloid polyneuropathy
Authors (first, second and last of 8)
- Antoine Rousseau
- Emmanuel Barreau
- David Adams
- Content type: Oral presentation
- Open Access
- Published: 02 November 2015
- Article: O19
-
Phase 2 open-label extention (OLE) study of patisiran, an investigational siRNA agent for familial amyloidotic polyneuropathy (FAP)
Authors (first, second and last of 8)
- David Adams
- Ole B Suhr
- Teresa Coehlo
- Content type: Oral presentation
- Open Access
- Published: 02 November 2015
- Article: O20
-
Phase 2, open-label extension (OLE) study of revusiran, an investigational RNAi therapeutic for the treatment of patients with transthyretin cardiac amyloidosis
Authors (first, second and last of 8)
- Julian D Gillmore
- Rodney H Falk
- Philip N Hawkins
- Content type: Oral presentation
- Open Access
- Published: 02 November 2015
- Article: O21
-
The ISIS-TTRRx-CS2 phase 3 study in patients with familial amyloid polyneuropathy: Baseline results of the first 100 patients for the NIS, NIS+7 and mNIS+7 using different methods of scoring: identification of consistencies and key differences
Authors (first, second and last of 5)
- Rito Bergemann
- Elizabeth Ackermann
- Peter Dyck
- Content type: Oral presentation
- Open Access
- Published: 02 November 2015
- Article: O22
-
Diflunisal therapy for cardiac ATTR amyloidosis: a longitudinal, prospective, single centre study
Authors (first, second and last of 8)
- Candida C Quarta
- Sevda Ozer
- Julian D Gillmore
- Content type: Oral presentation
- Open Access
- Published: 02 November 2015
- Article: O23
-
Diflunisal in late-onset FAP patients with moderate to severe neuropathy
Authors (first, second and last of 7)
- Laura Obici
- Andrea Cortese
- Giampaolo Merlini
- Content type: Oral presentation
- Open Access
- Published: 02 November 2015
- Article: O24
-
Familial Amyloid Polyneuropathy treatment with Tafamidis – evaluation of one- and two-year treatment in Porto, Portugal
Authors (first, second and last of 8)
- Teresa Coelho
- Ana Martins da Silva
- Vanessa Costa
- Content type: Oral presentation
- Open Access
- Published: 02 November 2015
- Article: O25